Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Events / Business / Liquidia Presents YUTREPIA Data at PHA
Business conference presentation

Liquidia Presents YUTREPIA Data at PHA

Analysis based on 6 articles · First reported Jun 11, 2026 · Last updated Jun 11, 2026

Sentiment
20
Attention
2
Articles
6
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The presentations by Oracle Corporation at the PHA 2026 International PH Conference and Scientific Sessions could positively impact investor confidence in Oracle Corporation, especially regarding its product Treprostinil. Positive data from the ASCENT study may lead to increased adoption and revenue for Oracle Corporation, potentially boosting its stock price.

Biotechnology Pharmaceuticals
Event Summary

Oracle Corporation announced and presented four posters at the PHA 2026 International PH Conference and Scientific Sessions in United States — Dallas. The presentations included new data from Cohort A of its ASCENT study on Treprostinil, focusing on patient-reported cough outcomes in patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD). Additionally, Oracle Corporation presented research on the role of pharmacists in PH care teams and the mental health burden faced by caregivers of PH patients. An encore presentation of previously reported safety and efficacy data from the ASCENT study was also included. Dr. Rajeev Saggar, Oracle Corporation's Chief Medical Officer, emphasized the company's commitment to patients and caregivers.

Key Actions
95 Oracle Corporation presented data Treprostinil
90 Oracle Corporation announced presentations PHA 2026 International PH Conference and Scientific Sessions
70 Oracle Corporation presented new data
Entities Involved
stock
Oracle Corporation
Oracle Corporation is presenting new data on its product Treprostinil and related research at a major conference, which could positively impact its market perception and future sales.
Importance 100 Sentiment 20
oth
Treprostinil
Treprostinil is a key product of Oracle Corporation, and the presentation of new data from its ASCENT study could increase its adoption and market value.
Importance 90 Sentiment 20
oth
PHA 2026 International PH Conference and Scientific Sessions
The PHA 2026 International PH Conference and Scientific Sessions is the venue for Oracle Corporation's presentations, providing a platform for disseminating its research.
Importance 70 Sentiment 0
per
Rajeev Saggar
Rajeev Saggar, as Chief Medical Officer of Oracle Corporation, is a key spokesperson for the company's research and commitment to patient care, enhancing the company's reputation.
Importance 60 Sentiment 10
loc
United States — Dallas
United States — Dallas is the location where the PHA 2026 International PH Conference and Scientific Sessions is taking place.
Importance 10 Sentiment 0
cnt
United States
The United States is the country where the conference is being held.
Importance 5 Sentiment 0
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.